Death following ceftazidime-induced Kounis syndrome

• Published in: Medico-legal journal Vol. 85; no. 4; pp. 215 - 218
• Main Authors: Kitulwatte, IDG, Gangahawatte, S, Perera, ULMS, Edirisinghe, PAS
• Format: Journal Article
• Language: English
• Published: London, England SAGE Publications 01.12.2017
• Subjects: allergy; myocardial cellular infiltration; ceftazidime; Kounis syndrome
• ISSN: 0025-8172; 2042-1834
• DOI: 10.1177/0025817217695904

Kounis syndrome, also known as allergic myocardial infarction or allergic angina syndrome, coincides with chest pain and allergic reactions. It involves the activation of interrelated inflammatory cells following allergic, anaphylactic or anaphylactoid insults. We report a case of Kounis syndrome complicated by an injection of ceftazidime. A 52-year-old man developed shortness of breath and hypotension, leading to immediate unconsciousness, after a ceftazidime injection. Despite intensive care management, he showed no improvement and died approximately 19 h after ceftazidime administration. Autopsy showed massive laryngeal oedema, mucous plugging and collapsed lungs. An ImmunoCAP tryptase assay showed the tryptase level in an autopsy sample to be 118 µg/L (normal < 11.4 µg/L). Microscopy of the myocardium showed cellular infiltration preceding myocardial necrosis. These findings support the pathophysiological theory of Kounis syndrome, with cellular infiltration proposed as the cause of myocardial injury rather than an effect related to the healing process.